Results 91 to 100 of about 10,082 (205)

Ocena jakości życia i satysfakcji z leczenia pacjentów z rozpoznaniem cukrzycy leczonych insuliną aspart oraz dwufazową insuliną aspart w stosunku 30/70 w porównaniu z terapią insuliną ludzką [PDF]

, 2008
The aim of this analysis was to compare quality of life and treatment satisfaction of patients with diagnosed type 1 or 2 diabetes mellitus treated with insulin aspart or biphasic insulin aspart 30/70 with those of patients, to whom therapy with human ...
Sieradzki, Jacek, Skrzekowska-Baran, Iwona, Koblik, Teresa; Katedra i Klinika Chorób Metabolicznych Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie   +2 more
core  

sj-docx-1-dst-10.1177_19322968241232709 – Supplemental material for Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial

Supplemental material, sj-docx-1-dst-10.1177_19322968241232709 for Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial ...
Wolfgang Schmider (6086591), Bhaswati Mukherjee (5346023), Lenore Teichert (18085455), Samer Nakhle (18085452), Baerbel Rotthaeuser (18085458), Viral N. Shah (5027201), Jose Mandry (18085449), Timothy S. Bailey (6933992), Daniel Kramer (2434054), Cathy Barnes (18085446), Suzanne Pierre (9871835), Amer Al-Karadsheh (18085443), Karin Wernicke-Panten (9871833)   +12 more
core   +1 more source

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Dubai cohort of the A 1 chieve study

, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Zain Gulzar, Thomas Zachariya, Laxami Sharma   +2 more
core   +1 more source

Use of fast\u2010acting insulin aspart in insulin pump therapy in clinical practice

, 2019
: Fast\u2010acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) containing the additional excipients niacinamide and L\u2010arginine. The improved pharmacological profile and greater early glucose\u2010lowering action of
Evans, Mark, Danne, Thomas, DeVries, J. Hans, de Block, Christophe, Wilmot, Emma G., Mathieu, Chantal, Ceriello, Antonio, Lind, Marcus, N\uf8rgaard, Kirsten, Renard, Eric   +9 more
core  

Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart — A secondary analysis of the CopenFast trial

Aims: We compared sensor-derived glycaemic metrics in pregnant women with type 1 diabetes (T1D) randomised to faster acting insulin aspart (faster aspart) or insulin aspart (IAsp). Methods: A pre-planned secondary analysis of the CopenFast trial included
Damm, Peter, Mathiesen, Elisabeth R., Clausen, Tine D., Ringholm, Lene, Søholm, Julie C., Nørgaard, Sidse K., Nørgaard, Kirsten   +6 more
core   +1 more source

A Pilot Study Evaluating Meal Timing, Macronutrient Composition, and Faster-Acting Insulin Aspart Versus Insulin Aspart on Postprandial Glycemia with the Medtronic Advanced Hybrid Closed-Loop System

A Pilot Study Evaluating Meal Timing, Macronutrient Composition, and Faster-Acting Insulin Aspart Versus Insulin Aspart on Postprandial Glycemia with the Medtronic Advanced Hybrid Closed-Loop ...
DJ Morrison (14472225), S Vogrin (12564715), Declan Hennessy (13066500), CE Smart (16197080), D O’Neal (22057793), B Grosman (13643788), L Robinson (7661600), A Roy (7299386), MH Lee (8002208), N Kurtz (13656232), E Netzer (19894707), HM Jones (22057790)   +11 more
core  

Faster-acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non-automated insulin pump and continuous glucose monitoring - A double-blind randomized controlled crossover trial

ObjectiveTo evaluate the efficacy and safety of faster-acting insulin aspart (faster aspart) compared with insulin aspart in adults with type 1 diabetes (T1D) using a non-automated insulin pump and continuous glucose monitoring (CGM).MethodsThis double ...
Ranjan, Ajenthen G., Schmidt, Signe, Nørgaard, Kirsten   +2 more
core   +1 more source

Mass Spectrometric Characterization of Native Insulin Hexamers and Non-Native Heptamers: Formation and Stability Across Insulin Analogs. [PDF]

J Mass Spectrom
Dare E, Dixon CG, Lee KW.
europepmc   +1 more source

Polyol-Functionalized Manganese-Based Nanoparticles: From Insulin Amyloid Inhibition to Nanozyme-Mediated Antioxidant Activity. [PDF]

Int J Mol Sci
Giannousi K, Kourpouanidou Z, Pantelidou E, Dendrinou-Samara C.   +3 more
europepmc   +1 more source

Incretin-based injectable strategies versus intensified insulin for treatment intensification and simplification in type 2 diabetes: a systematic review and meta-analysis. [PDF]

J Diabetes Metab Disord
Mahmood T, Myrtziou I, Kanakis I.
europepmc   +1 more source